Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0.571. It has been cited 44 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.571
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P01 NS09252
National Institutes of Health
Grant: F30 HL140871
National Institutes of Health
Grant: HL056687
National Institutes of Health
Grant: HL075443
National Institutes of Health
Grant: T32 GM007171
American Heart Association
Grant: 18PRE34060061
Fondation Leducq
Grant: 17 CVD 03
Be Brave for Life
Grant: not applicable
NHLBI NIH HHS
Grant: P01 HL075443
NHLBI NIH HHS
Grant: R01 HL056687
NIGMS NIH HHS
Grant: T32 GM145449
NINDS NIH HHS
Grant: P01 NS092521
National Institutes of Health
Grant: 2R01HL056687-18
Mechanisms of Maladaptation in Heart Failure
National Institutes of Health
Grant: 5P01NS092521-03
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis
National Institutes of Health
Grant: 5F30HL140871-02
Investigating the Molecular Pathways of Cerebral Cavernous Malformation Maturation
FWCI
2.61
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals